跳到正文
原文
Nature 健康护理主题·· 2026-10-14精选AI 评分69

自穴按压治疗芳香化酶抑制剂相关肌肉骨骼症状的随机临床试验

Randomized clinical trial of self-acupressure for aromatase-inhibitor associated musculoskeletal symptoms

AI 导读

一项在早期乳腺癌接受芳香化酶抑制剂治疗的患者中开展的随机对照试验发现,12周真实自穴按压与假按压相比,并未显著降低最严重疼痛评分(组间差异无统计学意义,p=0.88),真实按压组50%患者最严重疼痛改善≥2分,假按压组为41.2%(p=0.59),研究团队结论为该穴位处方自穴按压对芳香化酶抑制剂相关肌肉骨骼症状无明显疗效。

推荐理由

这是一项针对芳香化酶抑制剂相关肌肉骨骼症状的随机对照研究,结果为穴位按压无效,可补充该干预措施的证据等级。

正文 · 原文

npj Breast Cancer (2026) Cite this article

We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.

Abstract

Half of aromatase inhibitor (AI)-treated patients with early stage breast cancer discontinue therapy early, primarily because of AI-associated musculoskeletal symptoms (AIMSS). Acupuncture reduces AIMSS, but uptake is limited. Prior studies demonstrated reduction in pain with self-acupressure. We examined the effectiveness of 12 weeks of true (TA) versus sham (SA) acupressure for treating AIMSS. Patients with ≥4/10 new or worsening worst pain since starting AI therapy and no recent acupuncture were eligible. Median age was 51.6 years and 83% were white. Symptoms were assessed weekly using the Brief Pain Inventory (BPI). Primary endpoint was change in BPI worst pain by 12 weeks, analyzed using a linear mixed model. For the TA group (n = 25), worst pain decreased from 5.12 (SD 0.36) to 4.32 (SD 0.37). For the SA group (n = 23), worst pain decreased from 5.71 (SD 0.38) to 4.87 (SD 0.51). Difference by group over 12 weeks was not significant (p = 0.88). For those with both BPI assessments, 10 of 20 (50%) performing TA had ≥2 point improvement in worst pain, compared to 7 of 17 (41.2%) performing SA (p = 0.59). Although joint pain and stiffness improved with TA, improvements were not superior to SA. Acupressure using this acupoint formula does not appear to be effective for treatment of AIMSS.

Acknowledgements

For the purpose of open access, the author has applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission.

Funding

Supported by a grant from the Breast Cancer Research Foundation (BCRF-23-206 and BCRF-24-206) to N.L.H. The funder played no role in study design, data collection, analysis and interpretation of data, or the writing of this manuscript.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA

    NL Henry, S. Kozar, EF Cobain & M. Secor

  2. Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI, USA

    KA Griffith & KM Kidwell

  3. Michigan Medicine, Ann Arbor, MI, USA

    K. Scheu & J. Armstrong

  4. Department of Family Medicine, University of Michigan Medical School, Ann Arbor, MI, USA

    S. Snyder & SM Zick

Authors

  1. NL Henry
  2. KA Griffith
  3. KM Kidwell
  4. S. Kozar
  5. K. Scheu
  6. EF Cobain
  7. J. Armstrong
  8. M. Secor
  9. S. Snyder
  10. SM Zick

Corresponding author

Correspondence to NL Henry.

Ethics declarations

Competing interests

The authors declare no competing financial or non-financial interests. N.L.H. serves as a consultant or advisor to Genentech, Daiichi Sankyo, AstraZeneca, and Genentech, and receives royalties from Wolters Kluwer, none of which are relevant to this manuscript.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Henry, N., Griffith, K., Kidwell, K. et al. Randomized clinical trial of self-acupressure for aromatase-inhibitor associated musculoskeletal symptoms. npj Breast Cancer (2026). https://doi.org/10.1038/s41523-026-01066-0

Download citation

  • Received: 01 June 2026

  • Accepted: 28 September 2026

  • Published: 14 October 2026

  • DOI: https://doi.org/10.1038/s41523-026-01066-0

来源:Nature 健康护理主题 · nature.com